...
首页> 外文期刊>Seminars in cancer biology >The role of the organ microenvironment in brain metastasis.
【24h】

The role of the organ microenvironment in brain metastasis.

机译:器官微环境在脑转移中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

More than 40% of patients with lung cancer and breast cancer develop brain metastasis. With improved local control and therapy of metastasis to visceral organs, the morbidity and mortality due to late diagnosed brain metastasis are projected to rise. The median survival for untreated patients is 1-2 months, which may be extended to 6 months with surgery, radiotherapy, and chemotherapy. The development of a relevant mouse model for the establishment and growth of brain metastasis has advanced our understanding of the biology and therapy of this most feared consequence of cancer. Injection of murine or human tumor cells into the internal carotid artery of mice produces experimental metastases in specific regions of the brain that are not due to patterns of initial cell arrest, motility, or invasiveness, but rather to the ability of metastatic tumor cells to exploit homeostatic mechanisms and proliferate. Immunohistochemical and morphometric analyses demonstrate that the density of blood vessels within experimental metastases in brains of mice or in clinical specimen of human lung cancer brain metastases is lower than that in the adjacent tumor-free brain parenchyma. However, brain metastasis-associated blood vessels are dilated and contain numerous dividing endothelial cells. Immunohistochemical analysis also reveals that tumor cells located less than 100 mum from a blood vessel are viable, whereas more distant tumor cells undergo apoptosis. Tumor cells within brain metastasis produce VEGF which induces permeability in adjacent vessels. The BBB in metastases that are larger than 0.25 mm in diameter is leaky. Metastases in the brain are resistant to chemotherapeutic drugs. The venerable "seed and soil" hypothesis suggests that the outcome of metastasis depends on the interaction between unique tumor cells and the specific organ microenvironment. The demonstration that activated astrocytes whose physiological role is to protect neurons from toxic substances can be exploited by tumor cells for protection from chemotherapeutic drugs suggests new approaches to the treatment of this fatal disease.
机译:超过40%的肺癌和乳腺癌患者会发生脑转移。随着局部控制的改善和内脏器官转移的治疗,预计晚期诊断为脑转移的发病率和死亡率将上升。未经治疗的患者的中位生存期为1-2个月,通过手术,放疗和化疗可延长至6个月。用于建立和发展脑转移的相关小鼠模型的发展,使我们对这种最担心的癌症后果的生物学和治疗方法有了更深入的了解。将鼠类或人类肿瘤细胞注射到小鼠的颈内动脉中会在大脑的特定区域产生实验性转移,这不是由于最初的细胞停滞,运动或侵袭的模式,而是由于转移性肿瘤细胞的利用能力稳态机制和扩散。免疫组织化学和形态计量学分析表明,小鼠脑或人肺癌脑转移的临床标本中实验转移灶中的血管密度低于相邻的无肿瘤脑实质中的血管密度。然而,与脑转移相关的血管被扩张并且包含许多分裂的内皮细胞。免疫组织化学分析还显示,距离血管不到100毫米的肿瘤细胞是可行的,而距离较远的肿瘤细胞则发生凋亡。脑转移瘤细胞产生VEGF,诱导邻近血管的通透性。直径大于0.25 mm的转移灶中的BBB漏气。大脑中的转移灶对化学治疗药物具有抵抗力。古老的“种子和土壤”假说表明,转移的结果取决于独特的肿瘤细胞与特定器官微环境之间的相互作用。肿瘤细胞可以利用活化的星形胶质细胞(其生理学作用是保护神经元免受毒性物质侵袭)来保护其免受化学治疗药物的攻击,这表明了治疗这种致命疾病的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号